Non-Current Assets

Equity Method Investment Basis Difference

Boston Scientific Equity Method Investment Basis Difference decreased by 10.9% to $334.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.7%, from $374.00M to $334.00M.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026

How to read this metric

Large differences may indicate significant intangible assets or goodwill embedded within the investment value.

Detailed definition

The difference between the carrying value of an investment accounted for under the equity method and the company's share...

Peer comparison

Commonly reported by firms with significant minority stakes in joint ventures or strategic partners.

Metric ID: equity_method_investments_basis_diff

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$314.00M$289.00M$237.00M$233.00M$242.00M$209.00M$230.00M$236.00M$237.00M$233.00M$255.00M$374.00M$321.00M$375.00M$334.00M
QoQ Change-8.0%-18.0%-1.7%+3.9%-13.6%+10.0%+2.6%+0.4%-1.7%+9.4%+46.7%-14.2%+16.8%-10.9%
YoY Change-25.8%-16.3%-11.8%-1.3%-2.5%+13.4%+1.3%+8.1%+57.8%+37.8%+47.1%-10.7%
Range$209.00M$375.00M
CAGR+1.8%
Avg YoY Growth+8.1%
Median YoY Growth+0.0%

Frequently Asked Questions

What is Boston Scientific's equity method investment basis difference?
Boston Scientific (BSX) reported equity method investment basis difference of $334.00M in Q1 2026.
How has Boston Scientific's equity method investment basis difference changed year-over-year?
Boston Scientific's equity method investment basis difference decreased by 10.7% year-over-year, from $374.00M to $334.00M.
What does equity method investment basis difference mean?
The gap between the book value of an investment and the underlying net assets of the company invested in.